ACS Combinatorial Science
RESEARCH ARTICLE
against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Bioorg. Med. Chem. Lett. 2004, 14, 1145–1149.
(6) Neves-Pinto, C.; Malta, V.; Pinto, M.; Santos, R.; Castro, S.;
Pinto, A. Structure-activity relationships for pyrido-, imidazo-, pyrazolo-,
pyrazino-, and pyrrolophenazinecarboxamides as topoisomerase-
targeted anticancer agents. J. Med. Chem. 2002, 45, 740–743.
(17) (a) Jiang, B.; Tu, S.-J.; Kaur, P.; Wever, W.; Li, G. Four-
component domino reaction leading to multifunctionalized quinazo-
lines. J. Am. Chem. Soc. 2009, 131, 11660–11661. (b) Jiang, B.; Li, C.; Shi,
F.; Tu, S.-J.; Kaur, P.; Wever, W.; Li, G. Four-component domino
reaction providing an easy access to multifunctionalized tricyclo-
[6.2.2.01,6]dodecane derivatives. J. Org. Chem. 2010, 75, 2962–2965.
(c) Ma, N.; Jiang, B.; Zhang, G.; Tu, S.-J.; Wever, W.; Li, G. New
multicomponent domino reactions (MDRs) in water: highly chemo-,
regio- and stereoselective synthesis of spiro{[1,3]dioxanopyridine}-4,6-
diones and pyrazolo[3,4-b]pyridines. Green Chem. 2010, 12, 1357–1361.
(18) (a) Wei, P.; Zhang, X.-H.; Tu, S.-J.; Yan, S.; Ying, H.-J.; Ouyang,
P.-K. New potential inhibitors of DNA topoisomerase. Part II: Design
and synthesis of β-lapachone derivatives under microwave irradiation.
Bioorg. Med. Chem. Lett. 2009, 19, 828–830. (b) Wang, X.-H.; Zhang,
X.-H.; Tu, S.-J.; Shi, F.; Zou, X.; Yan, S.; Han, Z.-G; Hao, W.-J.; Cao,
X.-D.; Wu, S.-S. A facile route to the synthesis of 1,4-pyranonaphtho-
quinone derivatives under microwave irradiation without catalyst.
J. Heterocycl. Chem. 2009, 46, 832–836.
(7) (a) Cartwright, D.; Chilton, W.; Benson, D. Pyrrolnitrin and
phenazine production by Pseudomonas cepacia, strain 5.5B, a biocontrol
agent of Rhizoctonia solani. Appl. Microbiol. Biotechnol. 1995, 43, 211–
216. (b) Ligon, J.; Dwight, S.; Hammer, P.; Torkewitz, N.; Hofmann, D.;
Kempf, H.; Pee, K. Natural products with antifungal activity from
Pseudomonas biocontrol bacteria. Pest. Manage. Sci. 2000, 56, 688–695.
(8) Muller, M.; Sorrell, T. Inhibition of the human platelet cycloox-
ygenase response by the naturally occurring phenazine derivative,
1-hydroxyphenazine. Prostaglandins 1995, 50, 301–311.
(9) (a) Rewcastle, G.; Denny, W.; Baguley, B. Potential antitumor
agents. 51. Synthesis and antitumor activity of substituted phenazine-1-
carboxamides. J. Med. Chem. 1987, 30, 843–851. (b) Funayama, S.; Eda,
S.; Komiyama, K.; Omura, S. Structure of phenazinomycin, a novel
antitumor antibiotic. Tetrahedron Lett. 1989, 30, 3151–3154. (c) Wang,
S.; Miller, W.; Milton, J.; Vicker, N.; Stewart, A.; Charlton, P.; Mistry, P.;
Hardick, D.; Denny, W. Structure-activity relationships for analogues
of the phenazine-based dual topoisomerase I/II inhibitor XR11576.
Bioorg. Med. Chem. Lett. 2002, 12, 415–418. (d) Vicker, N.; Burgess, L.;
Chuckowree, I.; Dodd, R.; Folkes, A.; Hardick, D.; Hancox, T.; Miller,
W.; Milton, J.; Sohal, S.; Wang, S.; Wren, S.; Charlton, P.; Dangerfield,
W.; Liddle, C.; Mistry, P.; Stewart, A.; Denny, W. Novel angular
benzophenazines: Dual topoisomerase I and topoisomerase II inhibitors
as potential anticancer agents. J. Med. Chem. 2002, 45, 721–739. (e)
Gamage, S.; Spicer, J.; Rewcastle, G.; Milton, J.; Sohal, S.; Dangerfield,
W.; Mistry, P.; Vicker, N.; Charlton, P.; Denny, W. Structure-activity
relationships for pyrido-, imidazo-, pyrazolo-, pyrazino-, and pyrro-
lophenazinecarboxamides as topoisomerase-targeted anticancer agents.
J. Med. Chem. 2002, 45, 740–743.
(10) Curini, M.; Cravotto, G.; Epifano, F.; Giannone, G. Chemistry
and biological activity of natural and synthetic prenyloxycoumarins.
Curr. Med. Chem. 2006, 13, 199–222.
(11) (a) Yu, D.; Suzuki, M.; Xie, L.; Morris-Natschke, S. L.; Lee,
K.-H. Recent progress in the development of coumarin derivatives as
potent anti-HIV agents. Med. Res. Rev. 2003, 23, 322–345. (b) Abd El-
Aziz, A. S.; El-Agrody, A. M.; Bedair, A. H.; Corkery, T. C.; Ata, A.
Synthesis of hydroxyquinoline derivatives, aminohydroxychromene,
aminocoumarin and their antibacterial activities. Heterocycles 2004, 63,
1793–1812. (c) Borges, F.; Roleira, F.; Milhazes, N.; Santana, L.; Uriarte,
E. Simple coumarins and analogues in medicinal chemistry: occurrence,
synthesis and biological activity. Curr. Med. Chem. 2005, 12, 887–916.
(12) (a) Tangmouo, J. G.; Meli, A. L.; Komguem, J.; Kuete, V.;
Ngounou, F. N.; Lontsi, D.; Beng, V. P.; Choudhary, M. I.; Sondengam,
B. L. Crassiflorone, a new naphthoquinone from Diospyros crassiflora
(Hien). Tetrahedron Lett. 2006, 47, 3067–3070. (b) Abd-El-Aziz, A. S.;
El-Agrody, A. M.; Bedair, A. H.; Corkery, T. C.; Ata, A. Synthesis of
hydroxyquinoline derivatives, aminohydroxychromene, aminocoumar-
in, and their antibacterial activities. Heterocycles 2004, 63, 1793–1812.
(13) (a) Kitamura, R. O. S.; Romoff, P.; Young, M. C. M.; Kato, M. J.;
Lago, J. H. G. Chromenes from peperomia serpens (Sw.) Loudon
(Piperaceae). Phytochemistry 2006, 67, 2398–2402. (b) Iqbal, M. C. M.;
Jayasinghe, U. L. B.; Herath, H. M. T. B.; Wijesekara, K. B.; Fujimoto, Y.
A fungistatic chromene from ageratum conyzoides. Phytoparasitica
2004, 32, 119–126. (c) Kraus, G. A.; Kim, I. A direct synthesis of
o-methyl claussequinone. J. Org. Chem. 2003, 68, 4517–4518.
(14) Laursen, J. B.; Nielsen, J. Phenazine natural products: Biosynthe-
sis, synthetic analogues, and biological activity. Chem. Rev. 2004, 104,
1663–1685.
(15) Ellis, G. P. Chromenes, chromanones, and chromones-intro-
duction. Chem. Heterocycl. Compd. 1977, 31, 1–10.
(16) Elisa, P.-S.; Jorge, S.-D.; Ana, E.-B.; Angel, G. R. Synthesis of 9-
and 10-membered macrolactones by selective ozonolysis of 1,4-diaza-
phenanthrene derivatives. Tetrahedron 2005, 61, 437–445.
139
dx.doi.org/10.1021/co1000376 |ACS Comb. Sci. 2011, 13, 135–139